These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35494494)

  • 1. Efficacy and Safety of Anti-Nerve Growth Factor Antibody Therapy for Hip and Knee Osteoarthritis: A Meta-analysis.
    Gao Y; Hu Z; Huang Y; Liu W; Ren C
    Orthop J Sports Med; 2022 Apr; 10(4):23259671221088590. PubMed ID: 35494494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does anti-nerve growth factor monoclonal antibody treatment have the potential to replace nonsteroidal anti-inflammatory drugs and opioids in treating hip or knee osteoarthritis? A systematic review of randomized controlled trials.
    Zhao D; Zeng LF; Liang GH; Pan JK; Luo MH; Han YH; Liu J; Yang WY
    EFORT Open Rev; 2022 Jul; 7(7):470-480. PubMed ID: 35900204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A systematic review of the efficacy and general safety of antibodies to NGF in the treatment of OA of the hip or knee.
    Schnitzer TJ; Marks JA
    Osteoarthritis Cartilage; 2015 Jan; 23 Suppl 1():S8-17. PubMed ID: 25527221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effectiveness of Anti-Nerve Growth Factor Monoclonal Antibodies in the Management of Pain in Osteoarthritis of the Hip and Knee: A PRISMA Systematic Review and Meta-Analysis.
    Seah KTM; Rammanohar J; Sutton J; To K; Khan WS
    Pain Med; 2021 May; 22(5):1185-1204. PubMed ID: 33616179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Tanezumab on Osteoarthritis Knee and Hip Pains: A Meta-Analysis of Randomized Controlled Trials.
    Chen J; Li J; Li R; Wang H; Yang J; Xu J; Zha Z
    Pain Med; 2017 Feb; 18(2):374-385. PubMed ID: 28034979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tanezumab administered as a fixed dosing regimen in patients with knee or hip osteoarthritis: a meta-analysis of randomized controlled phase III trials.
    Fan ZR; Ma JX; Wang Y; Chen HT; Lang S; Ma XL
    Clin Rheumatol; 2021 Jun; 40(6):2155-2165. PubMed ID: 33159281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Efficacy of Nerve Growth Factor Antibody for the Treatment of Osteoarthritis Pain and Chronic Low-Back Pain: A Meta-Analysis.
    Yang S; Huang Y; Ye Z; Li L; Zhang Y
    Front Pharmacol; 2020; 11():817. PubMed ID: 32694993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Based on minimal clinically important difference values, a moderate dose of tanezumab may be a better option for treating hip or knee osteoarthritis: a meta-analysis of randomized controlled trials.
    Zhao D; Luo MH; Pan JK; Zeng LF; Liang GH; Han YH; Liu J; Yang WY
    Ther Adv Musculoskelet Dis; 2022; 14():1759720X211067639. PubMed ID: 35069811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chondroitin for osteoarthritis.
    Singh JA; Noorbaloochi S; MacDonald R; Maxwell LJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD005614. PubMed ID: 25629804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial.
    Schnitzer TJ; Easton R; Pang S; Levinson DJ; Pixton G; Viktrup L; Davignon I; Brown MT; West CR; Verburg KM
    JAMA; 2019 Jul; 322(1):37-48. PubMed ID: 31265100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tanezumab for Patients with Osteoarthritis of the Knee: A Meta-Analysis.
    Kan SL; Li Y; Ning GZ; Yuan ZF; Chen LX; Bi MC; Sun JC; Feng SQ
    PLoS One; 2016; 11(6):e0157105. PubMed ID: 27294371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee.
    Spierings ELH; Fidelholtz J; Wolfram G; Smith MD; Brown MT; West CR
    Pain; 2013 Sep; 154(9):1603-1612. PubMed ID: 23707270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
    Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
    Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip.
    Tive L; Bello AE; Radin D; Schnitzer TJ; Nguyen H; Brown MT; West CR
    J Pain Res; 2019; 12():975-995. PubMed ID: 30936738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Whole-Body Vibration Therapy on Knee Osteoarthritis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Qiu CG; Chui CS; Chow SKH; Cheung WH; Wong RMY
    J Rehabil Med; 2022 Mar; 54():jrm00266. PubMed ID: 35174868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-nerve growth factor in the treatment of low back pain and radiculopathy: a systematic review and a meta-analysis.
    Leite VF; Buehler AM; El Abd O; Benyamin RM; Pimentel DC; Chen J; Hsing WT; Mazloomdoost D; Amadera JE
    Pain Physician; 2014; 17(1):E45-60. PubMed ID: 24452657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial.
    Hochberg MC; Carrino JA; Schnitzer TJ; Guermazi A; Walsh DA; White A; Nakajo S; Fountaine RJ; Hickman A; Pixton G; Viktrup L; Brown MT; West CR; Verburg KM
    Arthritis Rheumatol; 2021 Jul; 73(7):1167-1177. PubMed ID: 33538113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intra-articular viscosupplementation with hylan g-f 20 to treat osteoarthritis of the knee: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2005; 5(10):1-66. PubMed ID: 23074461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and Safety of Hylan versus Hyaluronic Acid in the Treatment of Knee Osteoarthritis.
    Dai WL; Lin ZM; Guo DH; Shi ZJ; Wang J
    J Knee Surg; 2019 Mar; 32(3):259-268. PubMed ID: 29618143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, General Safety, and Joint Safety of Tanezumab in Japanese Patients with Osteoarthritis: Subgroup Analyses from Two Randomized, Phase 3 Studies.
    Miki K; Ohta M; Abe M; Yoshimatsu H; Fujii K; Ebata N; West CR; Brown MT; Pixton G; Isogawa N
    Pain Ther; 2022 Sep; 11(3):827-844. PubMed ID: 35538185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.